Abstract
D-penicillamine is used for patients with primary biliary cirrhosis due to its hepatic copper decreasing and immunomodulatory potentials. The results from randomised clinical trials have been inconsistent.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Cochrane Database of Systematic Reviews |
| Udgave nummer | 4 |
| Sider (fra-til) | CD004789 |
| ISSN | 1469-493X |
| DOI | |
| Status | Udgivet - 2004 |
| Udgivet eksternt | Ja |
Fingeraftryk
Dyk ned i forskningsemnerne om 'D-penicillamine for primary biliary cirrhosis'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver